727. Do Probiotics Prevent Nosocomial Infection? YES
Session: Interactive Session: Clinical Controversies in Infectious Diseases
Friday, October 21, 2011: 2:15 PM
Room: Grand Ballroom (East-West)


Cynthia Sears, MD, FIDSA, Johns Hopkins University School of Medicine, Baltimore, MD

Cynthia L. Sears, M.D. received her medical degree from Thomas Jefferson Medical College followed by training in internal medicine at The New York Hospital in New York City. She trained in Infectious Diseases at the Memorial Sloan Kettering Cancer Institute and the University of Virginia where she was a member of the infectious diseases faculty until 1988. Subsequently, Dr. Sears joined the faculty at Johns Hopkins University School of Medicine where she is now a Professor of Medicine, Oncology and Molecular Microbiology and Immunology in the Divisions of Infectious Diseases, Gastroenterology and Tumor Immunology, Departments of Medicine and Oncology, Johns Hopkins University School of Medicine and the Bloomberg School of Public Health. She is an expert in foodborne and enteric infections and has studied the pathogenesis of enterotoxigenic Bacteroides fragilis (ETBF) both in the laboratory and in clinical settings over the past nearly 20 years. Her scientific work has been funded continuously by the NIH since 1993. Presently, Dr. Sears focuses her efforts on mouse and human studies to define how ETBF and the colonic microbiota induce chronic colonic inflammation and colon cancer. Dr. Sears has served as an Associate Editor for Clinical Infectious Diseases since 2000. She is also an active member of the Infectious Diseases Society of America (IDSA), currently serving on the Board of Directors of IDSA as Treasurer. She is the current President of the Anaerobe Society of the Americas.



Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.